Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-04-17 to 2023-04-18
Current total value of award: $1477.29
Description: 4560609190!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML